Scott T. Rottinghaus - Chief Medical Officer at Enanta Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
ENTA on Nasdaq
All Insider Reports
All Insider Reports

Scott T. Rottinghaus - trading volume in the past year for Enanta Pharmaceuticals Inc

Holdings reported by Scott T. Rottinghaus for Enanta Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18.8K $239K $12.73 Aug 8, 2024 Direct
Stock Option (Right to Buy) 80.6K Jul 15, 2024 Direct Common Stock

Transactions reported by Scott T. Rottinghaus for Enanta Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.